Loading patent…
AssigneeHughes Biotechnology Co., Ltd
InventorsShang-Ta Wang, Chen Hsu, Nan-Wei Su
Estimating the term…
The present invention provides a method for treatment or prevention of a disease associated with a decrease in bone mass comprising administering to a subject in need of such treatment a composition comprising an effective amount of genistein phosphate conjugate. The present invention also provides a method of improving bone architecture and bio-mechanical strength of bone comprising administering to a subject in need of such treatment of a composition comprising an effective amount of genistein phosphate conjugate. The present invention administering to a subject in need of such treatment a composition comprising an effective amount of genistein phosphate conjugate can effectively increase the oral bioavailability so as to reduce the symptoms and the risk of complications of menopausal women, increase bone mineral content, bone density and bio-mechanical strength of bone, and slow down osteoporosis.
A method for treatment or alleviation of postmenopausal primary osteoporosis or osteoporosis followed by ovariectomy comprising administering to a subject in need of such treatment a composition comprising an effective amount of genistein phosphate conjugate, wherein the effective amount of genistein phosphate conjugate of the composition is from about 0.5 mg/kg B.W./day to about 2.5 mg/kg B.W./day.
A method of improving bone architecture of a subject suffering from postmenopausal primary osteoporosis or osteoporosis followed by ovariectomy comprising administering to a subject in need of such treatment of a composition comprising an effective amount of genistein phosphate conjugate, wherein the effective amount of genistein phosphate conjugate of the composition is from about 0.5 mg/kg B.W./day to about 2.5 mg/kg B.W./day.
A method of increasing bio-mechanical strength of bone of a subject suffering from postmenopausal primary osteoporosis or osteoporosis followed by ovariectomy comprising administering to a subject in need of such treatment of a composition comprising an effective amount of genistein phosphate conjugate.
Dependencies are inferred from the claim text.